表紙
市場調查報告書
商品編碼
1028814

胰島素製劑的全球市場(2021年):新型冠狀病毒感染疾病(COVID-19)造成的成長和到2030年前的變化

Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球胰島素製劑市場調查,提供市場概要,市場趨勢與策略,新型冠狀病毒感染疾病(COVID-19)的影響,市場區隔·各地區的市場規模的變化與預測,合併·收購趨勢,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 胰島素製劑市場特徵

第3章 胰島素製劑市場趨勢與策略

第4章 新型冠狀病毒感染疾病(COVID-19)的影響

第5章 市場規模的變化與預測

  • 市場規模(2015年∼2020年)
    • 市場成長要素
    • 市場阻礙因素
  • 市場規模(2020年∼2025年)
    • 市場成長要素
    • 市場阻礙因素

第6章 胰島素製劑市場:各市場區隔

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)
    • 基礎·長時間作用型胰島素
    • 推注或速效胰島素
    • 傳統胰島素注射液
    • 組合胰島素
    • 生物相似藥胰島素
  • 市場區隔:各用途(2020年∼2025年·2030年)
    • II型糖尿病
    • I型糖尿病
    • 妊娠糖尿病
    • 糖尿病前期
  • 市場區隔:藥品各級(2020年∼2025年·2030年)
    • 首發醫藥品
    • 非專利處方藥(學名藥)
  • 市場區隔:各流通管道(2020年∼2025年·2030年)
    • 醫院藥局
    • 零售藥局
    • 藥妝店
    • 其他

第7章 全球胰島素製劑市場:各地各國

  • 各地區(2015年∼2020年·2020年∼2025年·2030年)
  • 各國(2015年∼2020年·2020年∼2025年·2030年)

第8章 亞太地區的胰島素製劑市場

  • 市場概要
  • 市場·地區資訊,COVID-19的影響,背景,政府措施,法規,法規機關,公司稅結構等
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第9章 中國的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第10章 印度的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第11章 日本的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第12章 澳洲的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第13章 印尼的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第14章 韓國的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第15章 西歐的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第16章 英國的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第17章 德國的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第18章 法國的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第19章 東歐的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第20章 俄羅斯的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第21章 北美的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第22章 美國的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第23章 南美的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第24章 巴西的胰島素製劑市場

  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第25章 中東的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第26章 非洲的胰島素製劑市場

  • 市場概要
  • 市場區隔:各產品類型(2015年∼2020年·2020年∼2025年·2030年)

第27章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Apidra
    • Eli Lilly
    • Humalog
    • Humulin
    • Insuman

第28章 開發平台分析

第29章 合併·收購

第30章 未來展望與潛在性分析

第31章 附錄

目錄
Product Code: h838

“Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global insulin drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the insulin drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Insulin Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider insulin drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The insulin drugs market section of the report gives context. It compares the insulin drugs market with other segments of the insulin drugs market by size and growth, historic and forecast.

Scope

Markets Covered:

1) By Product Type: Basal or Long Acting Insulins; Bolus or Fast-Acting Insulins; Traditional Human Insulins; Combination Insulins; Biosimilar Insulins

2) By Application: Type II Diabetes; Type I Diabetes; Gestational Diabetes; Prediabetes

3) By Drug Classification: Branded Drugs; Generic Drugs

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drugs Stores; Others

Companies Mentioned: Apidra; Eli Lilly; Humalog; Humulin; Insuman

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Insulin Drugs Market Characteristics

3. Insulin Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Insulin Drugs

5. Insulin Drugs Market Size And Growth

  • 5.1. Global Insulin Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Insulin Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Insulin Drugs Market Segmentation

  • 6.1. Global Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Basal or Long Acting Insulins
  • Bolus or Fast-Acting Insulins
  • Traditional Human Insulins
  • Combination Insulins
  • Biosimilar Insulins
  • 6.2. Global Insulin Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Type II Diabetes
  • Type I Diabetes
  • Gestational Diabetes
  • Prediabetes
  • 6.3. Global Insulin Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 6.4. Global Insulin Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drugs Stores
  • Others

7. Insulin Drugs Market Regional And Country Analysis

  • 7.1. Global Insulin Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Insulin Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Insulin Drugs Market

  • 8.1. Asia-Pacific Insulin Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Insulin Drugs Market

  • 9.1. China Insulin Drugs Market Overview
  • 9.2. China Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Insulin Drugs Market

  • 10.1. India Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Insulin Drugs Market

  • 11.1. Japan Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Insulin Drugs Market

  • 12.1. Australia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Insulin Drugs Market

  • 13.1. Indonesia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Insulin Drugs Market

  • 14.1. South Korea Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Insulin Drugs Market

  • 15.1. Western Europe Insulin Drugs Market Overview
  • 15.2. Western Europe Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Insulin Drugs Market

  • 16.1. UK Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Insulin Drugs Market

  • 17.1. Germany Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Insulin Drugs Market

  • 18.3. France Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Insulin Drugs Market

  • 19.1. Eastern Europe Insulin Drugs Market Overview
  • 19.2. Eastern Europe Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Insulin Drugs Market

  • 20.1. Russia Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Insulin Drugs Market

  • 21.1. North America Insulin Drugs Market Overview
  • 21.2. North America Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Insulin Drugs Market

  • 22.1. USA Insulin Drugs Market Overview
  • 22.2. USA Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Insulin Drugs Market

  • 23.1. South America Insulin Drugs Market Overview
  • 23.2. South America Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Insulin Drugs Market

  • 24.1. Brazil Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Insulin Drugs Market

  • 25.1. Middle East Insulin Drugs Market Overview
  • 25.2. Middle East Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Insulin Drugs Market

  • 26.1. Africa Insulin Drugs Market Overview
  • 26.2. Africa Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Insulin Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Insulin Drugs Market Competitive Landscape
  • 27.2. Insulin Drugs Market Company Profiles
    • 27.2.1. Apidra
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Eli Lilly
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Humalog
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Humulin
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Insuman
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Insulin Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Insulin Drugs Market

30. Insulin Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer